Global Multi-Cancer Detection Blood Test Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Multi-Cancer Detection Blood Test Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Multi-Cancer Detection Blood Test Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 ctDNA-Based Tests
  • 1.2.3 Protein Biomarker-Based Tests
  • 1.2.4 Methylation-Based Tests
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Multi-Cancer Detection Blood Test Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Hospitals
  • 1.3.3 Diagnostic Laboratories
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Multi-Cancer Detection Blood Test Sales Estimates and Forecasts 2018-2029
• 2.2 Global Multi-Cancer Detection Blood Test Revenue by Region
  • 2.2.1 Global Multi-Cancer Detection Blood Test Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Multi-Cancer Detection Blood Test Revenue by Region (2018-2023)
  • 2.2.3 Global Multi-Cancer Detection Blood Test Revenue by Region (2024-2029)
  • 2.2.4 Global Multi-Cancer Detection Blood Test Revenue Market Share by Region (2018-2029)
• 2.3 Global Multi-Cancer Detection Blood Test Sales Estimates and Forecasts 2018-2029
• 2.4 Global Multi-Cancer Detection Blood Test Sales by Region
  • 2.4.1 Global Multi-Cancer Detection Blood Test Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Multi-Cancer Detection Blood Test Sales by Region (2018-2023)
  • 2.4.3 Global Multi-Cancer Detection Blood Test Sales by Region (2024-2029)
  • 2.4.4 Global Multi-Cancer Detection Blood Test Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Multi-Cancer Detection Blood Test Sales by Manufacturers
  • 3.1.1 Global Multi-Cancer Detection Blood Test Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Multi-Cancer Detection Blood Test Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Multi-Cancer Detection Blood Test in 2022
• 3.2 Global Multi-Cancer Detection Blood Test Revenue by Manufacturers
  • 3.2.1 Global Multi-Cancer Detection Blood Test Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Multi-Cancer Detection Blood Test Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Multi-Cancer Detection Blood Test Revenue in 2022
• 3.3 Global Key Players of Multi-Cancer Detection Blood Test, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Multi-Cancer Detection Blood Test Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Multi-Cancer Detection Blood Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Product Offered and Application
• 3.8 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Multi-Cancer Detection Blood Test Sales by Type
  • 4.1.1 Global Multi-Cancer Detection Blood Test Historical Sales by Type (2018-2023)
  • 4.1.2 Global Multi-Cancer Detection Blood Test Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• 4.2 Global Multi-Cancer Detection Blood Test Revenue by Type
  • 4.2.1 Global Multi-Cancer Detection Blood Test Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Multi-Cancer Detection Blood Test Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• 4.3 Global Multi-Cancer Detection Blood Test Price by Type
  • 4.3.1 Global Multi-Cancer Detection Blood Test Price by Type (2018-2023)
  • 4.3.2 Global Multi-Cancer Detection Blood Test Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Multi-Cancer Detection Blood Test Sales by Application
  • 5.1.1 Global Multi-Cancer Detection Blood Test Historical Sales by Application (2018-2023)
  • 5.1.2 Global Multi-Cancer Detection Blood Test Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• 5.2 Global Multi-Cancer Detection Blood Test Revenue by Application
  • 5.2.1 Global Multi-Cancer Detection Blood Test Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Multi-Cancer Detection Blood Test Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• 5.3 Global Multi-Cancer Detection Blood Test Price by Application
  • 5.3.1 Global Multi-Cancer Detection Blood Test Price by Application (2018-2023)
  • 5.3.2 Global Multi-Cancer Detection Blood Test Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Multi-Cancer Detection Blood Test Market Size by Type
  • 6.1.1 US & Canada Multi-Cancer Detection Blood Test Sales by Type (2018-2029)
  • 6.1.2 US & Canada Multi-Cancer Detection Blood Test Revenue by Type (2018-2029)
• 6.2 US & Canada Multi-Cancer Detection Blood Test Market Size by Application
  • 6.2.1 US & Canada Multi-Cancer Detection Blood Test Sales by Application (2018-2029)
  • 6.2.2 US & Canada Multi-Cancer Detection Blood Test Revenue by Application (2018-2029)
• 6.3 US & Canada Multi-Cancer Detection Blood Test Market Size by Country
  • 6.3.1 US & Canada Multi-Cancer Detection Blood Test Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
  • 6.3.3 US & Canada Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Multi-Cancer Detection Blood Test Market Size by Type
  • 7.1.1 Europe Multi-Cancer Detection Blood Test Sales by Type (2018-2029)
  • 7.1.2 Europe Multi-Cancer Detection Blood Test Revenue by Type (2018-2029)
• 7.2 Europe Multi-Cancer Detection Blood Test Market Size by Application
  • 7.2.1 Europe Multi-Cancer Detection Blood Test Sales by Application (2018-2029)
  • 7.2.2 Europe Multi-Cancer Detection Blood Test Revenue by Application (2018-2029)
• 7.3 Europe Multi-Cancer Detection Blood Test Market Size by Country
  • 7.3.1 Europe Multi-Cancer Detection Blood Test Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
  • 7.3.3 Europe Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Multi-Cancer Detection Blood Test Market Size
  • 8.1.1 China Multi-Cancer Detection Blood Test Sales (2018-2029)
  • 8.1.2 China Multi-Cancer Detection Blood Test Revenue (2018-2029)
• 8.2 China Multi-Cancer Detection Blood Test Market Size by Application
  • 8.2.1 China Multi-Cancer Detection Blood Test Sales by Application (2018-2029)
  • 8.2.2 China Multi-Cancer Detection Blood Test Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Multi-Cancer Detection Blood Test Market Size by Type
  • 9.1.1 Asia Multi-Cancer Detection Blood Test Sales by Type (2018-2029)
  • 9.1.2 Asia Multi-Cancer Detection Blood Test Revenue by Type (2018-2029)
• 9.2 Asia Multi-Cancer Detection Blood Test Market Size by Application
  • 9.2.1 Asia Multi-Cancer Detection Blood Test Sales by Application (2018-2029)
  • 9.2.2 Asia Multi-Cancer Detection Blood Test Revenue by Application (2018-2029)
• 9.3 Asia Multi-Cancer Detection Blood Test Sales by Region
  • 9.3.1 Asia Multi-Cancer Detection Blood Test Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Multi-Cancer Detection Blood Test Revenue by Region (2018-2029)
  • 9.3.3 Asia Multi-Cancer Detection Blood Test Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Galleri
  • 11.1.1 Galleri Company Information
  • 11.1.2 Galleri Overview
  • 11.1.3 Galleri Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Galleri Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Galleri Recent Developments
• 11.2 Amadix
  • 11.2.1 Amadix Company Information
  • 11.2.2 Amadix Overview
  • 11.2.3 Amadix Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Amadix Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Amadix Recent Developments
• 11.3 Burning Rock
  • 11.3.1 Burning Rock Company Information
  • 11.3.2 Burning Rock Overview
  • 11.3.3 Burning Rock Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Burning Rock Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Burning Rock Recent Developments
• 11.4 Exact Sciences
  • 11.4.1 Exact Sciences Company Information
  • 11.4.2 Exact Sciences Overview
  • 11.4.3 Exact Sciences Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 Exact Sciences Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Exact Sciences Recent Developments
• 11.5 Freenome
  • 11.5.1 Freenome Company Information
  • 11.5.2 Freenome Overview
  • 11.5.3 Freenome Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Freenome Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Freenome Recent Developments
• 11.6 AnchorDx
  • 11.6.1 AnchorDx Company Information
  • 11.6.2 AnchorDx Overview
  • 11.6.3 AnchorDx Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 AnchorDx Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 AnchorDx Recent Developments
• 11.7 Guardant Health
  • 11.7.1 Guardant Health Company Information
  • 11.7.2 Guardant Health Overview
  • 11.7.3 Guardant Health Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Guardant Health Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Guardant Health Recent Developments
• 11.8 Foundation Medicine
  • 11.8.1 Foundation Medicine Company Information
  • 11.8.2 Foundation Medicine Overview
  • 11.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Foundation Medicine Recent Developments
• 11.9 GENECAST
  • 11.9.1 GENECAST Company Information
  • 11.9.2 GENECAST Overview
  • 11.9.3 GENECAST Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 GENECAST Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 GENECAST Recent Developments
• 11.10 Coyne Medical
  • 11.10.1 Coyne Medical Company Information
  • 11.10.2 Coyne Medical Overview
  • 11.10.3 Coyne Medical Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 Coyne Medical Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Coyne Medical Recent Developments
• 11.11 Laboratory for Advanced Medicine
  • 11.11.1 Laboratory for Advanced Medicine Company Information
  • 11.11.2 Laboratory for Advanced Medicine Overview
  • 11.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Laboratory for Advanced Medicine Recent Developments
• 11.12 Singlera Genomics
  • 11.12.1 Singlera Genomics Company Information
  • 11.12.2 Singlera Genomics Overview
  • 11.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Singlera Genomics Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Multi-Cancer Detection Blood Test Industry Chain Analysis
• 12.2 Multi-Cancer Detection Blood Test Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Multi-Cancer Detection Blood Test Production Mode & Process
• 12.4 Multi-Cancer Detection Blood Test Sales and Marketing
  • 12.4.1 Multi-Cancer Detection Blood Test Sales Channels
  • 12.4.2 Multi-Cancer Detection Blood Test Distributors
• 12.5 Multi-Cancer Detection Blood Test Customers

13 Market Dynamics

• 13.1 Multi-Cancer Detection Blood Test Industry Trends
• 13.2 Multi-Cancer Detection Blood Test Market Drivers
• 13.3 Multi-Cancer Detection Blood Test Market Challenges
• 13.4 Multi-Cancer Detection Blood Test Market Restraints

14 Key Findings in The Global Multi-Cancer Detection Blood Test Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Multi-Cancer Detection Blood Test Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of ctDNA-Based Tests
• Table 3. Major Manufacturers of Protein Biomarker-Based Tests
• Table 4. Major Manufacturers of Methylation-Based Tests
• Table 5. Major Manufacturers of Others
• Table 6. Global Multi-Cancer Detection Blood Test Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 7. Global Multi-Cancer Detection Blood Test Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 8. Global Multi-Cancer Detection Blood Test Revenue by Region (2018-2023) & (US$ Million)
• Table 9. Global Multi-Cancer Detection Blood Test Revenue by Region (2024-2029) & (US$ Million)
• Table 10. Global Multi-Cancer Detection Blood Test Revenue Market Share by Region (2018-2023)
• Table 11. Global Multi-Cancer Detection Blood Test Revenue Market Share by Region (2024-2029)
• Table 12. Global Multi-Cancer Detection Blood Test Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 13. Global Multi-Cancer Detection Blood Test Sales by Region (2018-2023) & (K Units)
• Table 14. Global Multi-Cancer Detection Blood Test Sales by Region (2024-2029) & (K Units)
• Table 15. Global Multi-Cancer Detection Blood Test Sales Market Share by Region (2018-2023)
• Table 16. Global Multi-Cancer Detection Blood Test Sales Market Share by Region (2024-2029)
• Table 17. Global Multi-Cancer Detection Blood Test Sales by Manufacturers (2018-2023) & (K Units)
• Table 18. Global Multi-Cancer Detection Blood Test Sales Share by Manufacturers (2018-2023)
• Table 19. Global Multi-Cancer Detection Blood Test Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 20. Global Multi-Cancer Detection Blood Test Revenue Share by Manufacturers (2018-2023)
• Table 21. Global Key Players of Multi-Cancer Detection Blood Test, Industry Ranking, 2021 VS 2022 VS 2023
• Table 22. Multi-Cancer Detection Blood Test Price by Manufacturers 2018-2023 (US$/Unit)
• Table 23. Global Multi-Cancer Detection Blood Test Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 24. Global Multi-Cancer Detection Blood Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multi-Cancer Detection Blood Test as of 2022)
• Table 25. Global Key Manufacturers of Multi-Cancer Detection Blood Test, Manufacturing Base Distribution and Headquarters
• Table 26. Global Key Manufacturers of Multi-Cancer Detection Blood Test, Product Offered and Application
• Table 27. Global Key Manufacturers of Multi-Cancer Detection Blood Test, Date of Enter into This Industry
• Table 28. Mergers & Acquisitions, Expansion Plans
• Table 29. Global Multi-Cancer Detection Blood Test Sales by Type (2018-2023) & (K Units)
• Table 30. Global Multi-Cancer Detection Blood Test Sales by Type (2024-2029) & (K Units)
• Table 31. Global Multi-Cancer Detection Blood Test Sales Share by Type (2018-2023)
• Table 32. Global Multi-Cancer Detection Blood Test Sales Share by Type (2024-2029)
• Table 33. Global Multi-Cancer Detection Blood Test Revenue by Type (2018-2023) & (US$ Million)
• Table 34. Global Multi-Cancer Detection Blood Test Revenue by Type (2024-2029) & (US$ Million)
• Table 35. Global Multi-Cancer Detection Blood Test Revenue Share by Type (2018-2023)
• Table 36. Global Multi-Cancer Detection Blood Test Revenue Share by Type (2024-2029)
• Table 37. Multi-Cancer Detection Blood Test Price by Type (2018-2023) & (US$/Unit)
• Table 38. Global Multi-Cancer Detection Blood Test Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 39. Global Multi-Cancer Detection Blood Test Sales by Application (2018-2023) & (K Units)
• Table 40. Global Multi-Cancer Detection Blood Test Sales by Application (2024-2029) & (K Units)
• Table 41. Global Multi-Cancer Detection Blood Test Sales Share by Application (2018-2023)
• Table 42. Global Multi-Cancer Detection Blood Test Sales Share by Application (2024-2029)
• Table 43. Global Multi-Cancer Detection Blood Test Revenue by Application (2018-2023) & (US$ Million)
• Table 44. Global Multi-Cancer Detection Blood Test Revenue by Application (2024-2029) & (US$ Million)
• Table 45. Global Multi-Cancer Detection Blood Test Revenue Share by Application (2018-2023)
• Table 46. Global Multi-Cancer Detection Blood Test Revenue Share by Application (2024-2029)
• Table 47. Multi-Cancer Detection Blood Test Price by Application (2018-2023) & (US$/Unit)
• Table 48. Global Multi-Cancer Detection Blood Test Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 49. US & Canada Multi-Cancer Detection Blood Test Sales by Type (2018-2023) & (K Units)
• Table 50. US & Canada Multi-Cancer Detection Blood Test Sales by Type (2024-2029) & (K Units)
• Table 51. US & Canada Multi-Cancer Detection Blood Test Revenue by Type (2018-2023) & (US$ Million)
• Table 52. US & Canada Multi-Cancer Detection Blood Test Revenue by Type (2024-2029) & (US$ Million)
• Table 53. US & Canada Multi-Cancer Detection Blood Test Sales by Application (2018-2023) & (K Units)
• Table 54. US & Canada Multi-Cancer Detection Blood Test Sales by Application (2024-2029) & (K Units)
• Table 55. US & Canada Multi-Cancer Detection Blood Test Revenue by Application (2018-2023) & (US$ Million)
• Table 56. US & Canada Multi-Cancer Detection Blood Test Revenue by Application (2024-2029) & (US$ Million)
• Table 57. US & Canada Multi-Cancer Detection Blood Test Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 58. US & Canada Multi-Cancer Detection Blood Test Revenue by Country (2018-2023) & (US$ Million)
• Table 59. US & Canada Multi-Cancer Detection Blood Test Revenue by Country (2024-2029) & (US$ Million)
• Table 60. US & Canada Multi-Cancer Detection Blood Test Sales by Country (2018-2023) & (K Units)
• Table 61. US & Canada Multi-Cancer Detection Blood Test Sales by Country (2024-2029) & (K Units)
• Table 62. Europe Multi-Cancer Detection Blood Test Sales by Type (2018-2023) & (K Units)
• Table 63. Europe Multi-Cancer Detection Blood Test Sales by Type (2024-2029) & (K Units)
• Table 64. Europe Multi-Cancer Detection Blood Test Revenue by Type (2018-2023) & (US$ Million)
• Table 65. Europe Multi-Cancer Detection Blood Test Revenue by Type (2024-2029) & (US$ Million)
• Table 66. Europe Multi-Cancer Detection Blood Test Sales by Application (2018-2023) & (K Units)
• Table 67. Europe Multi-Cancer Detection Blood Test Sales by Application (2024-2029) & (K Units)
• Table 68. Europe Multi-Cancer Detection Blood Test Revenue by Application (2018-2023) & (US$ Million)
• Table 69. Europe Multi-Cancer Detection Blood Test Revenue by Application (2024-2029) & (US$ Million)
• Table 70. Europe Multi-Cancer Detection Blood Test Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 71. Europe Multi-Cancer Detection Blood Test Revenue by Country (2018-2023) & (US$ Million)
• Table 72. Europe Multi-Cancer Detection Blood Test Revenue by Country (2024-2029) & (US$ Million)
• Table 73. Europe Multi-Cancer Detection Blood Test Sales by Country (2018-2023) & (K Units)
• Table 74. Europe Multi-Cancer Detection Blood Test Sales by Country (2024-2029) & (K Units)
• Table 75. China Multi-Cancer Detection Blood Test Sales by Type (2018-2023) & (K Units)
• Table 76. China Multi-Cancer Detection Blood Test Sales by Type (2024-2029) & (K Units)
• Table 77. China Multi-Cancer Detection Blood Test Revenue by Type (2018-2023) & (US$ Million)
• Table 78. China Multi-Cancer Detection Blood Test Revenue by Type (2024-2029) & (US$ Million)
• Table 79. China Multi-Cancer Detection Blood Test Sales by Application (2018-2023) & (K Units)
• Table 80. China Multi-Cancer Detection Blood Test Sales by Application (2024-2029) & (K Units)
• Table 81. China Multi-Cancer Detection Blood Test Revenue by Application (2018-2023) & (US$ Million)
• Table 82. China Multi-Cancer Detection Blood Test Revenue by Application (2024-2029) & (US$ Million)
• Table 83. Asia Multi-Cancer Detection Blood Test Sales by Type (2018-2023) & (K Units)
• Table 84. Asia Multi-Cancer Detection Blood Test Sales by Type (2024-2029) & (K Units)
• Table 85. Asia Multi-Cancer Detection Blood Test Revenue by Type (2018-2023) & (US$ Million)
• Table 86. Asia Multi-Cancer Detection Blood Test Revenue by Type (2024-2029) & (US$ Million)
• Table 87. Asia Multi-Cancer Detection Blood Test Sales by Application (2018-2023) & (K Units)
• Table 88. Asia Multi-Cancer Detection Blood Test Sales by Application (2024-2029) & (K Units)
• Table 89. Asia Multi-Cancer Detection Blood Test Revenue by Application (2018-2023) & (US$ Million)
• Table 90. Asia Multi-Cancer Detection Blood Test Revenue by Application (2024-2029) & (US$ Million)
• Table 91. Asia Multi-Cancer Detection Blood Test Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 92. Asia Multi-Cancer Detection Blood Test Revenue by Region (2018-2023) & (US$ Million)
• Table 93. Asia Multi-Cancer Detection Blood Test Revenue by Region (2024-2029) & (US$ Million)
• Table 94. Asia Multi-Cancer Detection Blood Test Sales by Region (2018-2023) & (K Units)
• Table 95. Asia Multi-Cancer Detection Blood Test Sales by Region (2024-2029) & (K Units)
• Table 96. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Type (2018-2023) & (K Units)
• Table 97. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Type (2024-2029) & (K Units)
• Table 98. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Type (2018-2023) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Type (2024-2029) & (US$ Million)
• Table 100. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Application (2018-2023) & (K Units)
• Table 101. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Application (2024-2029) & (K Units)
• Table 102. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Application (2018-2023) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Application (2024-2029) & (US$ Million)
• Table 104. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 105. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Country (2018-2023) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue by Country (2024-2029) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Country (2018-2023) & (K Units)
• Table 108. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales by Country (2024-2029) & (K Units)
• Table 109. Galleri Company Information
• Table 110. Galleri Description and Major Businesses
• Table 111. Galleri Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 112. Galleri Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 113. Galleri Recent Developments
• Table 114. Amadix Company Information
• Table 115. Amadix Description and Major Businesses
• Table 116. Amadix Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 117. Amadix Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 118. Amadix Recent Developments
• Table 119. Burning Rock Company Information
• Table 120. Burning Rock Description and Major Businesses
• Table 121. Burning Rock Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 122. Burning Rock Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 123. Burning Rock Recent Developments
• Table 124. Exact Sciences Company Information
• Table 125. Exact Sciences Description and Major Businesses
• Table 126. Exact Sciences Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 127. Exact Sciences Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 128. Exact Sciences Recent Developments
• Table 129. Freenome Company Information
• Table 130. Freenome Description and Major Businesses
• Table 131. Freenome Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 132. Freenome Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 133. Freenome Recent Developments
• Table 134. AnchorDx Company Information
• Table 135. AnchorDx Description and Major Businesses
• Table 136. AnchorDx Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 137. AnchorDx Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 138. AnchorDx Recent Developments
• Table 139. Guardant Health Company Information
• Table 140. Guardant Health Description and Major Businesses
• Table 141. Guardant Health Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 142. Guardant Health Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 143. Guardant Health Recent Developments
• Table 144. Foundation Medicine Company Information
• Table 145. Foundation Medicine Description and Major Businesses
• Table 146. Foundation Medicine Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 147. Foundation Medicine Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 148. Foundation Medicine Recent Developments
• Table 149. GENECAST Company Information
• Table 150. GENECAST Description and Major Businesses
• Table 151. GENECAST Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 152. GENECAST Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 153. GENECAST Recent Developments
• Table 154. Coyne Medical Company Information
• Table 155. Coyne Medical Description and Major Businesses
• Table 156. Coyne Medical Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 157. Coyne Medical Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 158. Coyne Medical Recent Developments
• Table 159. Laboratory for Advanced Medicine Company Information
• Table 160. Laboratory for Advanced Medicine Description and Major Businesses
• Table 161. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 162. Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 163. Laboratory for Advanced Medicine Recent Developments
• Table 164. Singlera Genomics Company Information
• Table 165. Singlera Genomics Description and Major Businesses
• Table 166. Singlera Genomics Multi-Cancer Detection Blood Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 167. Singlera Genomics Multi-Cancer Detection Blood Test Product Model Numbers, Pictures, Descriptions and Specifications
• Table 168. Singlera Genomics Recent Developments
• Table 169. Key Raw Materials Lists
• Table 170. Raw Materials Key Suppliers Lists
• Table 171. Multi-Cancer Detection Blood Test Distributors List
• Table 172. Multi-Cancer Detection Blood Test Customers List
• Table 173. Multi-Cancer Detection Blood Test Market Trends
• Table 174. Multi-Cancer Detection Blood Test Market Drivers
• Table 175. Multi-Cancer Detection Blood Test Market Challenges
• Table 176. Multi-Cancer Detection Blood Test Market Restraints
• Table 177. Research Programs/Design for This Report
• Table 178. Key Data Information from Secondary Sources
• Table 179. Key Data Information from Primary Sources

List of Figures

• Figure 1. Multi-Cancer Detection Blood Test Product Picture
• Figure 2. Global Multi-Cancer Detection Blood Test Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Multi-Cancer Detection Blood Test Market Share by Type in 2022 & 2029
• Figure 4. ctDNA-Based Tests Product Picture
• Figure 5. Protein Biomarker-Based Tests Product Picture
• Figure 6. Methylation-Based Tests Product Picture
• Figure 7. Others Product Picture
• Figure 8. Global Multi-Cancer Detection Blood Test Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 9. Global Multi-Cancer Detection Blood Test Market Share by Application in 2022 & 2029
• Figure 10. Hospitals
• Figure 11. Diagnostic Laboratories
• Figure 12. Others
• Figure 13. Multi-Cancer Detection Blood Test Report Years Considered
• Figure 14. Global Multi-Cancer Detection Blood Test Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 15. Global Multi-Cancer Detection Blood Test Revenue 2018-2029 (US$ Million)
• Figure 16. Global Multi-Cancer Detection Blood Test Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 17. Global Multi-Cancer Detection Blood Test Revenue Market Share by Region (2018-2029)
• Figure 18. Global Multi-Cancer Detection Blood Test Sales 2018-2029 ((K Units)
• Figure 19. Global Multi-Cancer Detection Blood Test Sales Market Share by Region (2018-2029)
• Figure 20. US & Canada Multi-Cancer Detection Blood Test Sales YoY (2018-2029) & (K Units)
• Figure 21. US & Canada Multi-Cancer Detection Blood Test Revenue YoY (2018-2029) & (US$ Million)
• Figure 22. Europe Multi-Cancer Detection Blood Test Sales YoY (2018-2029) & (K Units)
• Figure 23. Europe Multi-Cancer Detection Blood Test Revenue YoY (2018-2029) & (US$ Million)
• Figure 24. China Multi-Cancer Detection Blood Test Sales YoY (2018-2029) & (K Units)
• Figure 25. China Multi-Cancer Detection Blood Test Revenue YoY (2018-2029) & (US$ Million)
• Figure 26. Asia (excluding China) Multi-Cancer Detection Blood Test Sales YoY (2018-2029) & (K Units)
• Figure 27. Asia (excluding China) Multi-Cancer Detection Blood Test Revenue YoY (2018-2029) & (US$ Million)
• Figure 28. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales YoY (2018-2029) & (K Units)
• Figure 29. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue YoY (2018-2029) & (US$ Million)
• Figure 30. The Multi-Cancer Detection Blood Test Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 31. The Top 5 and 10 Largest Manufacturers of Multi-Cancer Detection Blood Test in the World: Market Share by Multi-Cancer Detection Blood Test Revenue in 2022
• Figure 32. Global Multi-Cancer Detection Blood Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 33. Global Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• Figure 34. Global Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• Figure 35. Global Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• Figure 36. Global Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• Figure 37. US & Canada Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• Figure 38. US & Canada Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• Figure 39. US & Canada Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• Figure 40. US & Canada Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• Figure 41. US & Canada Multi-Cancer Detection Blood Test Revenue Share by Country (2018-2029)
• Figure 42. US & Canada Multi-Cancer Detection Blood Test Sales Share by Country (2018-2029)
• Figure 43. U.S. Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 44. Canada Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 45. Europe Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• Figure 46. Europe Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• Figure 47. Europe Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• Figure 48. Europe Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• Figure 49. Europe Multi-Cancer Detection Blood Test Revenue Share by Country (2018-2029)
• Figure 50. Europe Multi-Cancer Detection Blood Test Sales Share by Country (2018-2029)
• Figure 51. Germany Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 52. France Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 53. U.K. Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 54. Italy Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 55. Russia Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 56. China Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• Figure 57. China Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• Figure 58. China Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• Figure 59. China Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• Figure 60. Asia Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• Figure 61. Asia Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• Figure 62. Asia Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• Figure 63. Asia Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• Figure 64. Asia Multi-Cancer Detection Blood Test Revenue Share by Region (2018-2029)
• Figure 65. Asia Multi-Cancer Detection Blood Test Sales Share by Region (2018-2029)
• Figure 66. Japan Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 67. South Korea Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 68. China Taiwan Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 69. Southeast Asia Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 70. India Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 71. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
• Figure 72. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
• Figure 73. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
• Figure 74. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
• Figure 75. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Revenue Share by Country (2018-2029)
• Figure 76. Middle East, Africa and Latin America Multi-Cancer Detection Blood Test Sales Share by Country (2018-2029)
• Figure 77. Brazil Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 78. Mexico Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 79. Turkey Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 80. Israel Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 81. GCC Countries Multi-Cancer Detection Blood Test Revenue (2018-2029) & (US$ Million)
• Figure 82. Multi-Cancer Detection Blood Test Value Chain
• Figure 83. Multi-Cancer Detection Blood Test Production Process
• Figure 84. Channels of Distribution
• Figure 85. Distributors Profiles
• Figure 86. Bottom-up and Top-down Approaches for This Report
• Figure 87. Data Triangulation
• Figure 88. Key Executives Interviewed